Region
Featured experience
Meituan $717 million acquisition of Dingdong’s China business
We are advising Meituan on the transaction
MiniMax Group HK$4.8 billion IPO
We advised MiniMax Group on its IPO and HKEX listing
Baidu CNY4.4 billion notes offering
The investment-grade notes are due 2029
Tencent €1.16 billion investment in new Ubisoft subsidiary
We are advising Tencent on the transaction
Adagene $161 million IPO
We advised Adagene on its IPO and Nasdaq listing
China SCE $350 million high-yield notes offering
We advised the initial purchasers on the Regulation S senior notes offering
Hopson Development $100 million high-yield notes reopening
We advised the initial purchasers on the Regulation S senior notes offering
Ocumension Therapeutics HK$793.8 million top-up placement of shares
We advised the placing agent in connection with the equity offering
Ronshine China Holdings $200 million high-yield notes offering
We advised the initial purchasers on the Regulation S offering
Venus Medtech HK$1.4 billion placing of new H shares
We advised Venus Medtech (Hangzhou) on its placement of new shares
Guorui Properties exchange offer and consent solicitation
We advised the dealer manager on the transaction
Primavera Capital Acquisition $414 million IPO
We advised Primavera, a SPAC, on its IPO and NYSE listing
Innovent Biologics HK$4.73 billion placement of shares
We advised the joint placing agents in connection with the equity offering
Ronshine China Holdings $300 million high-yield notes offering
We advised the initial purchaser on the Regulation S offering